Displaying drugs 326 - 350 of 357 in total
Iopydol
Experimental
Matched Categories: … Contrast Media ... X-Ray Contrast Media, Iodinated ... Non-Watersoluble X-Ray Contrast Media …
CTX110
CTX110 is an allogeneic CRISPR/Cas9-mediated genetically modified CAR T cell therapy targeting CD19 antigen.
Investigational
Benfluorex
Benfluorex is an anorectic and hypolipidemic agent that is structurally related to fenfluramine. It was patented and manufactured by a French pharmaceutical company Servier. The European Medicines Agency (EMA) recommended withdrawing all benfluorex containing medicines on 18 December 2009. This recommendation was based on the risks (especially fenfluramine-like cardiovascular side-effects)...
Investigational
Withdrawn
Methiodal
Experimental
Matched Categories: … Contrast Media ... X-Ray Contrast Media, Iodinated ... Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media …
CTX120
CTX120 is an allogeneic CRISPR/Cas9-mediated genetically modified CAR T cell therapy targeting B-cell maturation antigen.
Investigational
Ioglicic acid
Experimental
Matched Categories: … Contrast Media ... X-Ray Contrast Media, Iodinated ... Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media …
Diodone
Experimental
Matched Categories: … Contrast Media ... X-Ray Contrast Media, Iodinated ... Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media …
TG4023
Investigational
Faropenem medoxomil
Faropenem medoxomil is an ester prodrug derivative of the beta-lactam antibiotic faropenem. The prodrug form of faropenem offers dramatically improved oral bioavailability and leads to higher systemic concentrations of the drug. Faropenem medoxomil is a broad-spectrum antibiotic that is highly resistant to beta-lactamase degradation. It is being developed jointly by...
Investigational
Iopentol
Iopentol is used as a contrast medium.
Experimental
Matched Categories: … Contrast Media ... X-Ray Contrast Media, Iodinated ... Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media …
Iotroxic acid
Iotroxic acid is a contrast medium molecule.
Experimental
Withdrawn
Matched Categories: … Contrast Media ... X-Ray Contrast Media, Iodinated ... Watersoluble, Hepatotropic X-Ray Contrast Media …
Iobenzamic acid
Experimental
Matched Categories: … Contrast Media ... X-Ray Contrast Media, Iodinated ... Watersoluble, Hepatotropic X-Ray Contrast Media …
Iodoxamic acid
Radiopaque medium used in the diagnosis of gall bladder & bile duct diseases, usually as meglumine salt.
Experimental
Matched Categories: … Contrast Media ... X-Ray Contrast Media, Iodinated ... Watersoluble, Hepatotropic X-Ray Contrast Media …
Iodamide
Iodamide is a contrast medium molecule that is no longer marketed in the United States.
Withdrawn
Matched Categories: … Contrast Media ... X-Ray Contrast Media, Iodinated ... Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media …
Perflenapent
Dodecafluoropentane is also known as perfluoropentane or perflenapent.
Investigational
Withdrawn
Matched Categories: … Contrast Media ... Ultrasound Contrast Media …
CTX130
CTX130 is an allogeneic CRISPR/Cas9-mediated genetically modified CAR T cell therapy targeting CD70 antigen.
Investigational
Ioglycamic acid
Experimental
Matched Categories: … Contrast Media ... X-Ray Contrast Media, Iodinated ... Watersoluble, Hepatotropic X-Ray Contrast Media …
Acetrizoic acid
Acetrizoic acid presents the molecular formula of 3-acetamidol-2,4,6-triiodobenzoic acid and it is the first monomeric ionic compound used as an X-ray contrast agent. It was first synthesized by Wallingford in 1953 and it was filled in the FDA by the Johnson & Johnson subsidiary, Cilag Chemie AG, on February 8th,...
Withdrawn
Matched Categories: … Contrast Media ... X-Ray Contrast Media, Iodinated ... Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media …
Metrizamide
Metrizamide is a solute for density gradient centrifugation offering higher maximum solution density without the problems of increased viscosity. It is also used as a resorbable, non-ionic contrast medium.
Experimental
Matched Categories: … Contrast Media ... X-Ray Contrast Media, Iodinated ... Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media …
Iocarmic acid
Experimental
Matched Categories: … Contrast Media ... X-Ray Contrast Media, Iodinated ... Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media …
Perflubron
Perflubron (Oxygent) is being developed as an intravascular oxygen carrier designed to augment oxygen delivery in surgical patients.
Investigational
Matched Categories: … Contrast Media ... Magnetic Resonance Imaging Contrast Media …
EP-2104R
EP-2104R is an imaging pharmaceutical under development for the detection of blood clots. It is the first targeted high-resolution technique designed to visualize blood clots directly. It is being developed by EPIX Pharmaceuticals, Inc.
Investigational
Matched Categories: … Contrast Media …
AVR-RD-05
AVR-RD-05 is a gene therapy comprising genetically modified autologous stem cells transduced ex vivo with a lentiviral vector encoding the human iduronate-2-sulfatase (IDS) enzyme. It is under investigation for the treatment of Hunter Syndrome (Mucopolysaccharidosis Type II, MPSII).
Investigational
Matched Description: … AVR-RD-05 is a gene therapy comprising genetically modified autologous stem cells transduced _ex vivo …
Tozuleristide
Tozuleristide is under investigation in clinical trial NCT02464332 (Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery).
Investigational
Matched Categories: … Contrast Media …
Iodohippuric acid
Iodohippuric acid is under investigation in clinical trial NCT02599844 (Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults).
Investigational
Matched Categories: … Contrast Media …
Displaying drugs 326 - 350 of 357 in total